Patients of Lovelace Health System say they can't refill their prescriptions as the Albuquerque, N.M.-based system recovers from a cyberattack, Albuquerque Journal reported Dec. 1. 

House Republicans are investigating the FDA's regulation of a common decongestant found in over-the-counter cold medicines that the agency recently determined to be ineffective, The Hill reported Dec. 4. 

The FDA has granted approval to Eli Lilly and Company's drug Jaypirca, a therapy to treat chronic lymphocytic leukemia or small lymphocytic lymphoma.

More than three-fourths of hospital pharmacy leaders think health systems will cut service lines because of the rising cost and complexity of new drugs, according to a report released Dec. 4.

Morgantown, W.Va.-based WVU Medicine will operate a specialty pharmacy that is currently operated by Allied Health Services, WVU Medicine's for-profit organization. 

Pharmaceutical giant AbbVie announced plans to acquire antibody-drug conjugate maker ImmunoGen to expand its oncology portfolio and enter the commercial market for ovarian cancer. 

Pfizer's weight loss drug candidate, danuglipron, helped patients shed between 4.8% and 13% body weight in a clinical trial involving patients with and without obesity, but the drugmaker is canceling research after more than half stopped taking the drug.

Walgreens rolled out its new Rx Savings Finder on Nov. 30, a free tool offering discount cards for thousands of medications. 

Optum Rx, a subsidiary of UnitedHealth Group, is keeping close tabs on three drug candidates that might be approved in the next few months, according to its fall 2023 report. 

The FDA sent another warning to an Intas Pharmaceuticals plant in India, where investigators imposed import bans in late 2022 after finding shredded quality control documents doused in acid.